InVision AG
XETRA:IVX
InVision AG
XETRA:IVX
Price:
6
EUR
Market Closed
Market Cap:
€13.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
InVision AG
XETRA:IVX
|
DE |
|
China Aluminum International Engineering Corp Ltd
HKEX:2068
|
CN |
|
M
|
Meridian Bioscience Inc
LSE:0K0K
|
US |
|
Z
|
Zhejiang Wanfeng Chemical Co Ltd
SSE:603172
|
CN |
|
D
|
De Nora India Ltd
NSE:DENORA
|
IN |
|
Dhruv Consultancy Services Ltd
NSE:DHRUV
|
IN |
|
R
|
Reviv3 Procare Co
AMEX:AXIL
|
US |
|
S
|
Shanghai Universal Biotech Co Ltd
SZSE:301166
|
CN |
|
Arabian Internet and Communications Services Co CSJC
SAU:7202
|
SA |
|
Zhejiang Songyuan Automotive Safety Systems Co Ltd
SZSE:300893
|
CN |
|
BKM Industries Ltd
NSE:BKMINDST
|
IN |
|
Escorts Kubota Ltd
BSE:500495
|
IN |
Balance Sheet
Balance Sheet Decomposition
InVision AG
InVision AG
Balance Sheet Decomposition is not available for
InVision AG
InVision AG
Balance Sheet
InVision AG
InVision AG
Currency: EUR
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
5
|
3
|
1
|
4
|
2
|
1
|
3
|
8
|
6
|
6
|
|
| Cash Equivalents |
5
|
3
|
1
|
4
|
2
|
1
|
3
|
8
|
6
|
6
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
2
|
2
|
3
|
1
|
1
|
2
|
1
|
1
|
2
|
2
|
|
| Accounts Receivables |
2
|
2
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
6
|
7
|
4
|
6
|
4
|
2
|
4
|
9
|
8
|
8
|
|
| PP&E Net |
1
|
7
|
9
|
9
|
10
|
9
|
10
|
10
|
9
|
9
|
|
| PP&E Gross |
1
|
7
|
9
|
9
|
10
|
9
|
10
|
10
|
9
|
9
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
|
| Intangible Assets |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
0
|
0
|
0
|
0
|
4
|
3
|
2
|
1
|
|
| Total Assets |
9
N/A
|
15
+72%
|
14
-7%
|
16
+11%
|
14
-14%
|
12
-12%
|
18
+51%
|
22
+23%
|
20
-11%
|
19
-5%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Other Current Liabilities |
3
|
2
|
2
|
3
|
1
|
1
|
2
|
2
|
1
|
1
|
|
| Total Current Liabilities |
4
|
3
|
3
|
3
|
2
|
2
|
3
|
3
|
2
|
2
|
|
| Long-Term Debt |
0
|
4
|
3
|
2
|
2
|
0
|
2
|
6
|
6
|
9
|
|
| Total Liabilities |
4
N/A
|
7
+88%
|
6
-14%
|
5
-13%
|
3
-36%
|
2
-42%
|
5
+167%
|
9
+77%
|
8
-10%
|
11
+35%
|
|
| Equity | |||||||||||
| Common Stock |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Retained Earnings |
6
|
1
|
5
|
8
|
7
|
7
|
10
|
10
|
9
|
5
|
|
| Additional Paid In Capital |
9
|
8
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
5
N/A
|
8
+61%
|
8
-1%
|
11
+28%
|
10
-3%
|
10
-2%
|
13
+29%
|
13
+2%
|
12
-12%
|
8
-33%
|
|
| Total Liabilities & Equity |
9
N/A
|
15
+72%
|
14
-7%
|
16
+11%
|
14
-14%
|
12
-12%
|
18
+51%
|
22
+23%
|
20
-11%
|
19
-5%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
